MIRI

MIRI stands out in the health-engagement space by focusing on the moments between interactions—doses, appointments, refills, and purchases. Unlike generic engagement platforms that send mass messages, MIRI uses continuous AI conversation to capture real behavioral signals, turning every interaction into data that predicts churn, adherence, and repurchase intent. This is a significant advantage for GLP-1 and telehealth programs where retention directly impacts revenue and clinical outcomes. The platform’s measurable results—60% 30-day retention vs 6% benchmark, 9-16x retention lift, and 5.8x revenue potential—are compelling, though these are partner-reported and may not be universally replicable. Strengths: Deep focus on behavioral signal capture, proactive engagement between visits, and actionable intelligence for churn and cross-sell. Deployment in weeks, not years, is a plus. The platform integrates into existing ecosystems, avoiding rip-and-replace. Weaknesses: No public pricing or self-service—custom partnership model means you must engage sales. Deployment requires engineering resources for custom integration. Lack of detailed technical documentation and API specifics on the public site makes evaluation harder. Where it fits: GLP-1 programs, telehealth providers, lab diagnostics, supplement subscriptions, and EHR partners that have recurring engagement cycles and need to reduce churn and increase LTV. Where it doesn’t: small practices, one-time purchase retailers, or teams needing a simple mass-messaging tool with low effort.